Journey Medical (DERM) Return on Sales: 2021-2025
Historic Return on Sales for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -0.14%.
- Journey Medical's Return on Sales rose 17.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.26% for FY2024, which is 21.00% down from last year.
- Per Journey Medical's latest filing, its Return on Sales stood at -0.14% for Q3 2025, which was up 5.88% from -0.15% recorded in Q2 2025.
- In the past 5 years, Journey Medical's Return on Sales ranged from a high of 0.01% in Q2 2024 and a low of -0.70% during Q4 2021.
- Its 3-year average for Return on Sales is -0.23%, with a median of -0.15% in 2025.
- As far as peak fluctuations go, Journey Medical's Return on Sales plummeted by 33bps in 2022, and later surged by 65bps in 2024.
- Quarterly analysis of 5 years shows Journey Medical's Return on Sales stood at -0.70% in 2021, then climbed by 29bps to -0.40% in 2022, then surged by 35bps to -0.05% in 2023, then decreased by 21bps to -0.26% in 2024, then increased by 17bps to -0.14% in 2025.
- Its last three reported values are -0.14% in Q3 2025, -0.15% for Q2 2025, and -0.15% during Q1 2025.